iCAD, Inc.
ICADNASDAQHealthcare
$3.87
+$0.14(+3.75%)
Market Cap$106312383
P/E Ratio—
52W High$4.01
52W Low$1.19
iCAD, Inc. (ICAD) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ICAD · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2025Report Date: Aug 12, 2025EPS Actual
-$0.07
Est. -$0.06 · -27.3%
Revenue
—
Est. $0.00B
Fiscal Period
Q3 FY2025
FY ends December
Report Date
Aug 12, 2025
After Market Close
▼ Miss EPS
ICAD reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.06 | -$0.07 | -27.3% | — | $0.00B | — |
| ▲ Q2 FY2025 | May 13, 2025 | -$0.06 | -$0.02 | +66.7% | $0.00B | $0.00B | +0.6% |
| ▲ Q1 FY2025 | Mar 19, 2025 | -$0.05 | -$0.03 | +40.0% | $0.01B | $0.00B | +14.7% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.08 | -$0.07 | +12.5% | $0.00B | $0.00B | -6.3% |
| — Q3 FY2024 | Aug 13, 2024 | -$0.07 | -$0.07 | +0.0% | $0.01B | $0.00B | +13.8% |
| ▲ Q2 FY2024 | May 14, 2024 | -$0.06 | -$0.05 | +16.7% | $0.00B | $0.00B | +11.6% |
| ▲ Q1 FY2024 | Mar 12, 2024 | -$0.05 | -$0.02 | +60.0% | $0.00B | $0.00B | +10.3% |
| ▲ Q4 FY2023 | Nov 13, 2023 | -$0.09 | -$0.04 | +55.6% | $0.00B | $0.00B | -5.3% |
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.07
EPS Est.
-$0.06
EPS Surpr.
-27.3%
Revenue
—
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$0.02
EPS Est.
-$0.06
EPS Surpr.
+66.7%
Revenue
$0.00B
Q1 FY2025
Mar 19, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.05
EPS Surpr.
+40.0%
Revenue
$0.01B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$0.07
EPS Est.
-$0.08
EPS Surpr.
+12.5%
Revenue
$0.00B
Q3 FY2024
Aug 13, 2024
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.01B
Q2 FY2024
May 14, 2024Beat
EPS Actual
-$0.05
EPS Est.
-$0.06
EPS Surpr.
+16.7%
Revenue
$0.00B
Q1 FY2024
Mar 12, 2024Beat
EPS Actual
-$0.02
EPS Est.
-$0.05
EPS Surpr.
+60.0%
Revenue
$0.00B
Q4 FY2023
Nov 13, 2023Beat
EPS Actual
-$0.04
EPS Est.
-$0.09
EPS Surpr.
+55.6%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.03 | $-0.03 | $-0.03 | 2 |
| Q3 FY2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q2 FY2027 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q1 FY2027 | $-0.02 | $-0.02 | $-0.02 | 2 |
| Q4 FY2026 | $-0.04 | $-0.04 | $-0.04 | 2 |
| Q3 FY2026 | $-0.03 | $-0.03 | $-0.03 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2025 | Aug 12, 2025 | -27.3% | $3.87 | — | — |
| ▲ Q2 FY2025 | May 13, 2025 | +66.7% | $3.71 | $3.93 | +5.93% |
| ▲ Q1 FY2025 | Mar 19, 2025 | +40.0% | $2.32 | $2.47 | +6.47% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +12.5% | $2.40 | $2.34 | -2.50% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +0.0% | $1.34 | $1.36 | +1.49% |
| ▲ Q2 FY2024 | May 14, 2024 | +16.7% | $1.56 | $1.58 | +1.28% |
| ▲ Q1 FY2024 | Mar 12, 2024 | +60.0% | $1.76 | $1.73 | -1.70% |
| ▲ Q4 FY2023 | Nov 13, 2023 | +55.6% | $1.34 | $1.43 | +6.72% |
Q3 FY2025—
Report Date
Aug 12, 2025
EPS Beat/Miss
-27.3%
Price Before
$3.87
Price After
—
Q2 FY2025+5.93%
Report Date
May 13, 2025
EPS Beat/Miss
+66.7%
Price Before
$3.71
Price After
$3.93
Q1 FY2025+6.47%
Report Date
Mar 19, 2025
EPS Beat/Miss
+40.0%
Price Before
$2.32
Price After
$2.47
Q4 FY2024-2.50%
Report Date
Nov 13, 2024
EPS Beat/Miss
+12.5%
Price Before
$2.40
Price After
$2.34
Q3 FY2024+1.49%
Report Date
Aug 13, 2024
EPS Beat/Miss
+0.0%
Price Before
$1.34
Price After
$1.36
Q2 FY2024+1.28%
Report Date
May 14, 2024
EPS Beat/Miss
+16.7%
Price Before
$1.56
Price After
$1.58
Q1 FY2024-1.70%
Report Date
Mar 12, 2024
EPS Beat/Miss
+60.0%
Price Before
$1.76
Price After
$1.73
Q4 FY2023+6.72%
Report Date
Nov 13, 2023
EPS Beat/Miss
+55.6%
Price Before
$1.34
Price After
$1.43
Avg Beat Reaction+2.53%
Beat Rate7 / 8 quarters
Largest Move+6.72% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ICAD ends December
iCAD, Inc. (ICAD) most recently reported earnings on August 12, 2025 for Q3 FY2025, posting EPS of $-0.07 — missing the analyst consensus of $-0.06 by -27.3%. The next ICAD earnings date is expected around September 1, 2026.
Each quarter, investors track ICAD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ICAD revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ICAD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ICAD earnings · 5 questionsiCAD, Inc.'s next earnings report is expected around September 1, 2026. ICAD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ICAD historically reports after market close (AMC).
ICAD earnings datewhen is ICAD earningsICAD next earnings datewhen does ICAD report earningsICAD earnings calendar
▸ Source: FMP · iCAD, Inc. SEC filings · US GAAP · iCAD, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026